Diabetes Board decisions

The Board remands the claims for service connection and increased ratings due to pre-decisional duty to assist errors.

The Board granted service connection for diabetes mellitus type II, ischemic heart disease, and hypertension from August 10, 2022, under the PACT Act. The claim for a thyroid disability was denied.

The Board granted service connection for tinnitus and denied it for bilateral hearing loss. Other claims were remanded for further development.

The Board denied the veteran's claims for service connection and increased ratings, finding no evidence of a current disability or sufficient link to military service.

The Board denied service connection for type 2 diabetes mellitus as the evidence did not support a finding of in-service disease or injury indicative of type 2 diabetes mellitus, and there was no credible evidence to establish exposure to herbicide agents on a direct basis.

The Board denied service connection for diabetes mellitus as there was no evidence of a current disability. The claims for left ankle condition and heart condition were remanded for further development.

The Board granted service connection for diabetes mellitus II, as due to herbicide exposure during the Vietnam War under the PACT Act.

The Board denied service connection for diabetes mellitus type II and remanded the claim for further development regarding neuropathy of the left lower extremity.

The Board denied service connection for diabetes mellitus, type II and related conditions due to a lack of evidence linking the Veteran's current disabilities to his active service or toxic exposure at Camp Lejeune.

The Board remands the claims for service connection for left knee strain, right knee strain, and diabetes due to a need for additional medical opinions.

The Board granted earlier effective dates for the grant of service connection for chronic kidney disease, coronary artery disease, and diabetes mellitus, type II, from September 28, 2021. The claim for COPD was denied as no new and relevant evidence has been received.

The Board denied service connection for anxiety and a higher rating for PTSD, but remanded claims for diabetes mellitus, skin markings from toxic exposure, left knee disorder, right knee disorder, and lumbar spine disorder.

The Veteran's appeal for increased ratings was denied, except for a grant of TDIU effective May 30, 2023.

The Board denied an initial rating in excess of 50 percent for obstructive sleep apnea and remanded the claim for service connection for diabetes mellitus type II.

The Board denied service connection for a respiratory disability, to include asbestosis, and remanded claims for diabetes, hypertension, erectile dysfunction, and dental disabilities.

The appeal was denied due to the untimeliness of the higher-level review request and the failure to meet criteria for earlier effective dates and increased ratings for various service-connected conditions.

The Board granted service connection for diabetes mellitus, coronary artery disease, and hypertension based on the Veteran's exposure to herbicide agents while stationed in Guam.

The Board granted service connection for gangrenous gallbladder and hemorrhagic necrotizing pancreatitis, to include as due to Agent Orange exposure. Service connection was also granted for diabetes mellitus type I as secondary to the Veteran's service-connected hemorrhagic necrotizing pancreatitis. The Board denied a compensable rating for hypertension and noncompensable ratings for melanoma and squamous cell cancer removal scars (trunk) and facial scars.

The Board granted service connection for diabetic retinopathy, peripheral neuropathy of the upper extremities, kidney condition, obstructive sleep apnea, asthma, and tinnitus.

The appeal seeking revision on the basis of clear and unmistakable error (CUE) of the October 2015 rating decision that assigned an effective date of June 24, 2015, for the award of service connection for diabetes mellitus type II was denied. The October 2015 rating decision was revised to reflect an earlier effective date of June 24, 2014, for the award of service connection for coronary artery disease (CAD).